MicroPET imaging of a gastrin-releasing peptide receptor-positive tumor in a mouse model of human prostate cancer using a 64Cu-labeled bombesin analogue

被引:150
作者
Rogers, BE
Bigott, HM
McCarthy, DW
Della Manna, D
Kim, J
Sharp, TL
Welch, MJ
机构
[1] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL 35294 USA
[2] Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA
关键词
D O I
10.1021/bc034018l
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The gastrin-releasing peptide receptor (GRPR) is overexpressed on a variety of carcinomas and has been the target for detection and treatment of these neoplasms in animals. In particular, analogues of the tetradecapeptide bombesin (BN) have been radiolabeled with Tc-99m and In-111 for detection of GRPR-positive tumors by gamma ray scintigraphy. The goal of this study was to evaluate the potential of the bombesin analogue, DOTA-Aoc-BN(7-14), for positron-emission tomographic (PET) imaging after radiolabeling with the positron-emitter Cu-64. A saturation binding assay on PC-3 human prostate cancer cells showed that Cu-64-DOTA-Aoc-BN(7-14) had an equilibrium binding constant (K-d) of 6.1 +/-2.5 nM and a receptor concentration (B-max) of 2.7 +/- 0.6 x 10(5) receptors/cell. The radiolabeled analogue also showed rapid internalization with 18.2% internalized into 10(5) PC-3 cells by 2 h. The tumor localization of Cu-64-DOTA-Aoc-BN(7-14) was 5.5% injected dose per gram in athymic nude mice bearing PC-3 xenografts at 2 h postinjection. The tumor retention with respect to the 2 h value was 76% and 45% at 4 and 24 h, respectively, and was GRPR-mediated as shown by inhibition with a coinjection of excess peptide. MicroPET imaging of Cu-64-DOTA-Aoc-BN(7-14) in athymic nude mice bearing subcutaneous PC-3 tumors showed good tumor localization. Further studies with Cu-64 pyruvaldehyde-bis(N-4-methylthiosemicarbazone) (Cu-64-PTSM) suggested that low blood flow to the PC-3 tumors may have limited the localization of Cu-64-DOTA-Aoc-BN(7-14). This study demonstrates that Cu-64-DOTA-Aoc-BN(7-14) can be used to detect GRPR-positive tumors by PET imaging.
引用
收藏
页码:756 / 763
页数:8
相关论文
共 54 条
[51]   Technetium-99m RP527, a GRP analogue for visualisation of GRP receptor-expressing malignancies: a feasibility study [J].
Van de Wiele, C ;
Dumont, F ;
Vanden Broecke, R ;
Oosterlinck, W ;
Cocquyt, V ;
Serreyn, R ;
Peers, S ;
Thornback, J ;
Slegers, G ;
Dierckx, RA .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (11) :1694-1699
[52]   Is there a role for agonist gastrin-releasing peptide receptor radioligands in tumour imaging? [J].
Van de Wiele, C ;
Dumont, F ;
Van Belle, S ;
Slegers, G ;
Peers, SH ;
Dierckx, RA .
NUCLEAR MEDICINE COMMUNICATIONS, 2001, 22 (01) :5-15
[53]  
Van de Wiele CV, 2001, J NUCL MED, V42, P1722
[54]   NEUROMEDIN-B RECEPTOR IN ESOPHAGUS - EVIDENCE FOR SUBTYPES OF BOMBESIN RECEPTORS [J].
VONSCHRENCK, T ;
HEINZERIAN, P ;
MORAN, T ;
MANTEY, SA ;
GARDNER, JD ;
JENSEN, RT .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 256 (04) :G747-G758